Search

everythinglearnresearchcommunity

for

Search:↓

Shorter daylight increases hair growth in Cashmere goats.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Hair loss requires customized treatments based on its various causes and types.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Alefacept showed some effectiveness for alopecia areata but needs more research.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

The review found that different stem cell types in the skin are crucial for repair and could help treat skin diseases and cancer.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

The document concludes that understanding how adult stem and progenitor cells move is crucial for tissue repair and developing cell therapies.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.